In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

A PACS Pact

Executive Summary

An alliance between Hewlett-Packard, 3M and Cemax-Icon has created a new kind of PACS supplier.

You may also be interested in...



Emageon Inc.

Only 1% of US hospitals are filmless, despite years of hype about the advantages of transmitting, viewing and storing diagnostic images digitally. Two-year-old Emageon has designed a suite of services and software that address some of the reasons hospitals are hesitant to adopt digital archiving and transmission, notably cost and technical difficulties of handling large images digitally.

J&J Forecasts Strong Pharma Growth In 2021, But No COVID-19 Vaccine Update

Data from a high-profile Phase III COVID-19 vaccine trial will be released the first week of February, management said.

OTC Sanitizer Firm In China On US Import Alert, Warned After Twice Missing On GMP Compliance

Yuyao YiJia Daily Chemical told FDA placed all drugs it manufactures on import alert in September because its methods and controls for manufacturing OTC sanitizers and other products do not appear to conform to current drug GMPs.

Topics

UsernamePublicRestriction

Register

LL1135544

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel